Shilpa Ray

Publikationer
Forskningsbidrag
Populärvetenskap och samverkan

Artiklar

Article: SCIENTIFIC REPORTS. 2024;14(1):17820
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV
Narayanan A; Kieri O; Vesterbacka J; Manoharan L; Chen P; Ghorbani M; Ljunggren H-G; Chen MS; Aleman S; Soennerborg A; Ray S; Nowak P
Article: NPJ BIOFILMS AND MICROBIOMES. 2023;9(1):104
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
Ray S; Narayanan A; Vesterbacka J; Blennow O; Chen P; Gao Y; Gabarrini G; Ljunggren H-G; Buggert M; Manoharan L; Chen MS; Aleman S; Sonnerborg A; Nowak P
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023;61(5):106792
Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism
Cena-Diez R; Narayanan A; Ray S; van de Klundert M; Rodriguez JE; Nilvebrant J; Nygren P-A; Vegvari A; van Domselaar R; Sonnerborg A
Article: PROTEIN SCIENCE. 2022;31(4):835-849
Structural investigation on SPI-6-associated Salmonella typhimurium VirG-like stress protein that promotes pathogen survival in macrophages
Ray S; Pandey NK; Kushwaha GS; Das S; Ganguly AK; Vashi N; Kumar D; Suar M; Bhavesh NS
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:1079995
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
Ghorbani M; Al-Manei K; Naud S; Healy K; Gabarrini G; Sobkowiak MJ; Chen P; Ray S; Akber M; Muschiol S; Bogdanovic G; Bergman P; Ljungman P; Buggert M; Ljunggren H-G; Pin E; Nowak P; Aleman S; Saellberg Chen M
Article: JOURNAL OF VIROLOGY. 2021;95(18):e0047921-10.1128/jvi.00421
Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist
Sperk M; Ambikan AT; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sonnerborg A; Neogi U
Article: ACS INFECTIOUS DISEASES. 2021;7(5):1104-1115
Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
Ray S; Narayanan A; Giske CG; Neogi U; Sonnerborg A; Nowak P
Article: FRONTIERS IN MICROBIOLOGY. 2021;12:667718
Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
Bai X; Narayanan A; Nowak P; Ray S; Neogi U; Sonnerborg A

Alla övriga publikationer

Preprint: RESEARCH SQUARE. 2024
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV
Narayanan A; Kieri O; Vesterbacka J; Manoharan L; Chen P; Ghorbani M; Ljunggren H-G; Chen MS; Aleman S; Sönnerborg A; Ray S; Nowak P
Preprint: RESEARCH SQUARE. 2023
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
Ray S; Narayanan A; Vesterbacka J; Blennow O; Chen P; Gao Y; Gabarrini G; Ljunggren H-G; Buggert M; Manoharan L; Chen M; Aleman S; Sönnerborg A; Nowak P
Preprint: RESEARCH SQUARE. 2020
Novel mechanism of HIV elite control by enriching gut dipeptides as HIV-1 antagonist but Prevotella agonist
Sperk M; Ambikan A; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sönnerborg A; Neogi U

Forskningsbidrag

Identification of a Novel non-antibiotic Bactericidal agent to fight antimicrobial resistance
Swedish Research Council
1 January 2023 - 31 December 2025

Artiklar

Alla övriga publikationer

Forskningsbidrag

Nyheter från KI

Kalenderhändelser från KI